
The New York Times:
The health care products giant Johnson & Johnson continued to market an artificial hip in Europe and elsewhere overseas after the Food and Drug Administration rejected its sale in the United States based on a review of company safety studies.
Read the whole story at The New York Times
New report highlights metal hip implant problems | Reuters
Complaints Soar on Hip Implants as Dangers Are Studied ...
Looking for signs of hip-implant problems: You Docs | cleveland.com
Hip replacement - Wikipedia, the free encyclopedia
J & J DePuy Lawsuit. Defective Hip Replacement - ASR Hip Implant ...

The New York Times | By BARRY MEIER | Posted: 02/15/12 06:43 AM ET | Updated: 02/15/12 06:46 AM ET